Is nucleoside analogue monotherapy sufficient for treatment of HBV infection? Lessons from HIV.
Pillay
D
D
Cane
P A
PA
Mutimer
D
D
D015075:2-Aminopurine / Q000031:analogs & derivatives / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D003849:Deoxyguanosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077595:Famciclovir; D015658:HIV Infections / Q000188:drug therapy*; D006509:Hepatitis B / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D006147:Guanine / Q000031:analogs & derivatives
D015075:2-Aminopurine; D019380:Anti-HIV Agents; D000998:Antiviral Agents; D003849:Deoxyguanosine; D000077595:Famciclovir; D019259:Lamivudine; C413685:entecavir; D006147:Guanine